Azathioprine sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for azathioprine sodium and what is the scope of patent protection?
Azathioprine sodium
is the generic ingredient in two branded drugs marketed by Hikma and Casper Pharma Llc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for azathioprine sodium
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 16 |
Patent Applications: | 3 |
What excipients (inactive ingredients) are in azathioprine sodium? | azathioprine sodium excipients list |
DailyMed Link: | azathioprine sodium at DailyMed |
Recent Clinical Trials for azathioprine sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Hong Kong | Phase 2 |
AstraZeneca | Phase 3 |
Jiangsu Renocell Biotech Company | Phase 2 |
Pharmacology for azathioprine sodium
Drug Class | Purine Antimetabolite |
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for azathioprine sodium
US Patents and Regulatory Information for azathioprine sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Casper Pharma Llc | IMURAN | azathioprine sodium | INJECTABLE;INJECTION | 017391-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | AZATHIOPRINE SODIUM | azathioprine sodium | INJECTABLE;INJECTION | 074419-001 | Mar 31, 1995 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.